...control licenses for commercial cultivators, manufacturers, testing facilities, and more. A 15% sales tax on marijuana sales will be imposed. It is no secret that support for medical marijuana is...
...as well as enforce meaningful oversight and enforcement of state and federal mental health and substance use disorder parity laws, including requiring health insurance companies to demonstrate parity compliance at...
...comp claim populations are due to a combination of factors and efforts at federal, state, and individual program levels championed by workers’ compensation payers and PBMs. As we have seen...
...resiliency Medical program priorities Barriers to recovery Items that require more visibility Technology Claim complexity Obstacles for claims professionals Click here to view high-level results and access the complete report....
...for reporting an injury Stigma around workers’ comp patients across various stakeholders Plans for self-care Lack of direction from employers and insurers Approximately 25% of patients faced complications with receiving...
...much more than that, as this position comes with some opportunities to interact with stakeholders across the workers’ comp healthcare ecosystem and ease their experiences. “Workers’ comp is a high-touch...
...workers’ comp, including: Anticonvulsants Antidepressants Compounds Dermatological agents Musculoskeletal therapy agents Nonsteroidal anti-inflammatory drugs (NSAIDs) Opioids This study provides a high-level view of changing costs of prescription drugs in workers’...
...provide superior reduction in pain for patients in either clinical trial when compared with hydrocodone bitartrate/acetaminophen tablets (HB/APAP) – a common opioid-acetaminophen combination. How Safe Is It? Based on the...
...early risk warning signs For an in-depth look at the data, and what this means for the workers’ comp industry, click here to read the 2020 Workers’ Comp Industry Insights Survey....
...COVID-19 tests, though the FDA continues to monitor the effect of different variants on molecular tests. Negative test results should be considered in combination with clinical observations, patient history, and...
...workers’ comp 2025 Workers’ Comp Industry Insights Survey Report The top challenges and priorities in workers’ comp, based on the responses of 515 industry stakeholders, including a special Claims Professional...
...comp, and as a new brand drug may incur higher costs when generic medications are readily available. According to the FDA-approved drug label, Combogesic features similar warnings that respectively come...
...NCCI reported that at least 40 bills were in motion this year surrounding compensation for mental injuries, with more than 30 of those bills specifically mentioning PTSD, though states are...
The FDA has recently issued two separate communications regarding semaglutide – a drug gaining strong popularity for weight loss – noting concerns with compounded semaglutide, as well as reports of...
